August 22, 2022
The Krach Institute for Tech Diplomacy at Purdue has welcomed three new fellows. They will further the development in chemical engineering, advanced manufacturing, food safety, health equity, and professional management. Dr. Jan-Anders E. Mansson is an expert in design and manufacturing of "composite systems for high-performance applications of aerospace, automotive, and sports sectors," according to a recent release. Dr. Haley Oliver, provides expertise on foodborne pathogens in food systems such as cellular agriculture to the Krach Institute. Cristina Farmus is the chief of staff to the executive vice president for Strategic Initiatives at Purdue. She is currently involved in projects relating to semiconductor degrees and industry engagement, advanced pharmaceutical manufacturing and the study of nuclear energy.
August 17, 2022
The problematic combination of a rising prevalence of skin and soft tissue infections and the growing rate of life-threatening antibiotic resistant infections presents an urgent, unmet need for the healthcare industry. These evolutionary resistances originate from mutations in the bacterial cell walls which prevent effective diffusion of antibiotics. Gram-negative bacteria are of special consideration due to the natural resistance to many common antibiotics due to the unique bilayer structure of the cell wall. The system developed here provides one solution to this problem through a wearable therapy that delivers and utilizes gaseous ozone as an adjunct therapy with topical antibiotics through a novel dressing with drug-eluting nanofibers (NFs).
August 11, 2022
The Food and Drug Administration announced an emergency use authorization to move forward with their plan to stretch out the current monkeypox vaccine supply with a new injection method that will try to stretch one dose into five. Vaccine experts say that the scientific rationale behind this decision is sound, but technical challenges with the rollout technique may still be ahead.
FDA's move to stretch monkeypox vaccine supplies could pay off, experts say
August 11, 2022
Eight researchers from Purdue University are receiving a total of more than $470,000 from the university’s Trask Innovation Fund and Proof of Concept Fund. The university says the investment is designed to help the researchers commercialize their work. The Proof of Concept Fund recipients are listed below: Rahim Rahimi, College of Engineering, “Microneedle Array Patch for Wound Oxygenation and Biofilm Eradication,” – $89,604 Yoon Yeo, College of Pharmacy, “Flexible, Non-cationic, Cold Chain-Free Nanocarrier for Systemic Delivery of RNA Therapeutics,” – $98,629 Jeffrey Youngblood, College of Engineering, “Sustainable Lidded Rigid Trays for Food Packaging,” – $99,244
August 10, 2022
BioCrossroads, an Indianapolis-based firm that supports life science innovation by creating connections among corporations, universities and philanthropists, has singled out Lauren Ann Metskas for its 23 PAIR (Promising Achievers in Innovation and Research) recognition.
Metskas receives BioCrossroads recognition for novel research
August 10, 2022
Creating groundbreaking inventions to improve lives requires more than an idea: It needs research and development, which involves funding. Two Purdue University funds are helping researchers take those R&D steps. Eight Purdue University researchers have received more than $470,000 from the Trask Innovation Fund and Proof of Concept Fund to make their work more attractive for commercial use. The Proof of Concept Fund was established in 2021; this is its first round of funding. It invests up to $100,000 in select Purdue technologies for commercialization-directed research or related projects. Industry leaders are involved in the selection, design and oversight of the funded projects. Proof of Concept Fund recipients, their college, project title and total award amount are: Rahim Rahimi, College of Engineering, “Microneedle Array Patch for Wound Oxygenation and Biofilm Eradication,” $89,604. Yoon Yeo, College of Pharmacy, “Flexible, Non-cationic, Cold Chain-Free Nanocarrier for Systemic Delivery of RNA Therapeutics,” $98,629. Jeffrey P. Youngblood, College of Engineering, “Sustainable Lidded Rigid Trays for Food Packaging,” $99,244.
Eight Purdue researchers receive $470,000 to strengthen the marketplace appeal of their work
August 8, 2022
Amid a newly announced monkeypox national public emergency and shortage of vaccines, the Food and Drug Administration announced it is reviewing a new vaccine approach that could lead to a fivefold increase in the US’s supply of the Jynneos monkeypox vaccine.
What to know about monkeypox vaccination that could stretch supplies
August 3, 2022
A Purdue University chemical engineer has improved upon traditional methods to produce off-the-shelf human immune cells that show strong antitumor activity, according to a new article.
New patent-pending method mass-produces antitumor cells to treat blood diseases and cancer
August 3, 2022
Xiaoping Bao, an assistant professor of chemical engineering at Purdue University, has improved upon traditional methods of producing off-the-shelf human immune cells that show strong antitumor activity and can be used to treat blood diseases and cancer.
Purdue professor develops patent-pending method to treat blood diseases, cancer
July 25, 2022
NSF I-Corps Hub: Midwest Region Investigator(s): Nathalie Duval-Couetil, Theresa Stellwag Mayer**, Matthew Lynall, Sponsor: University of Michigan; Polytechnic: $87,881.40; Total: $3,081,111
